Flora Peyvandi: Intrinsic Thrombin Generation in Severe Hemophilia A
Flora Peyvandi, Professor of Internal Medicine at the University of Milan and former President of ISTH, shared a post on X about a recent article by Emma H. Urlings et al. published in Research and Practice in Thrombosis and Haemostasis, adding:
”Intrinsic Activated Thrombin Generation for Treatment Efficacy and Monitoring of Octocog Alpha and Emicizumab in Severe Hemophilia A – Research and Practice in Thrombosis and Haemostasis”
Title: Intrinsic Activated Thrombin Generation for Treatment Efficacy and Monitoring of Octocog Alpha and Emicizumab in Severe Hemophilia A
Authors: Emma H. Urlings, Floor C.J.I. Heubel-Moenen, René van Oerle, Dave L.S. Hellenbrand, Paola E.J. van der Meijden, Tilman M. Hackeng, Hugo ten Cate, Magdolna Nagy, Yvonne M.C. Henskens, Henri M.H. Spronk
Stay updated on all scientific advances with Hemostasis Today.
-
May 11, 2026, 15:28Does New DIC Terminology Improve Clarity or Increase Confusion?- JTH
-
May 11, 2026, 15:19Chokri Ben Lamine: Sepsis Induced Coagulopathy Is Not a Single Disease Phenotype
-
May 11, 2026, 15:10William Wallace: Why Vitamin C Is the Only Reason Your Collagen Doesn’t Melt at Body Temperature
-
May 11, 2026, 14:44World Thalassaemia Day: Building Care Around Patients – Novo Nordisk Haemophilia and Haemoglobinopathies Foundation
-
May 11, 2026, 14:43Arun Rajasekaran: Demonstrating an Association Between Serum Anti-PLA2R Ab and Thrombosis Risk
-
May 11, 2026, 14:42Julie Makani: WHO 2026 Guidelines on the Management of Childhood Illness for SCD
-
May 11, 2026, 14:41Rikke Johannessen: Acknowledging Africa CDC Leadership in Advancing Africa’s NCD Agenda
-
May 11, 2026, 14:41Ahmed Alanazi: Understanding the Causes of Hypercoagulation
-
May 11, 2026, 14:40Katerina Pavenski: What Should Be the Future Priorities in PBM